[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new formulation of a drug that treats a type of blood cancer. Originally approved in 2015, Darzalex
New Blood Cancer Rx Gets FDA Nod
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat multiple myeloma. This new approval is called Sarclisa (isatuximab-irfc). It is to be
New Rx Approvals | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved five medications in the last month. The FDA approved these medications to treat various conditions, ranging from a
Newer Blood Thinners Tied to Lower Bleeding Risk
[ad_1] (RxWiki News) Compared to a widely used older blood thinner, newer blood thinners may be linked to a reduced risk for serious bleeding, a new study found. This study
Rx for Low Platelet Counts Approved
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat low blood platelets, a condition known as thrombocytopenia. The FDA approved Doptelet (avatrombopag)
Approved: First Biosimilar to Treat Anemia
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat anemia. This new approval is a biosimilar found under the name Retacrit (epoetin
A New Treatment for a Rare Blood Cancer
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved the first treatment for a rare type of blood cancer. The agency expanded the approval of Zelboraf (vemurafenib)
New Lymphoma Rx Approved | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a medication to treat adults with mantle cell lymphoma. The FDA approved Calquence (acalabrutinib) to treat this fast-growing
Second US Gene Therapy Approved
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved the United States’ second gene therapy to treat certain types of lymphoma. Yescarta (axicabtagene ciloleucel) was approved to
New Lymphoma Rx Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new treatment for a type of non-Hodgkin lymphoma. The FDA approved Aliqopa (copanlisib) to treat relapsed follicular